BR0208814A - Uso de derivados de ariletenossulfonamida - Google Patents
Uso de derivados de ariletenossulfonamidaInfo
- Publication number
- BR0208814A BR0208814A BR0208814-2A BR0208814A BR0208814A BR 0208814 A BR0208814 A BR 0208814A BR 0208814 A BR0208814 A BR 0208814A BR 0208814 A BR0208814 A BR 0208814A
- Authority
- BR
- Brazil
- Prior art keywords
- pyrimidin
- derivatives
- phenylethenesulfonamide
- methoxyphenoxy
- methoxy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
"USO DE DERIVADOS DE ARILETENOSSULFONAMIDA". A invenção refere-se a um uso de N - [6 - metóxi - 5 -(2metoxifenóxi) - 2 - (pirimidin - 2 - il)pirimidin - 4 - il] - 2 - feniletenossulfonamida, ou um de seus sais farmaceuticamente aceitáveis. Isto é, uma composição farmacêutica para cura de disúria contendo N - [6 - metóxi - 5 -(2metoxifenóxi) - 2 - (pirimidin - 2 - il)pirimidin - 4 - il] - 2 - feniletenossulfonamida, ou um de seus sais farmaceuticamente aceitáveis como ingrediente ativo.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001114958 | 2001-04-13 | ||
PCT/JP2002/003624 WO2002083142A1 (fr) | 2001-04-13 | 2002-04-11 | Nouvelle utilisation du derive arylethenesulfonamide |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0208814A true BR0208814A (pt) | 2004-03-09 |
Family
ID=18965933
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0208814-2A BR0208814A (pt) | 2001-04-13 | 2002-04-11 | Uso de derivados de ariletenossulfonamida |
Country Status (10)
Country | Link |
---|---|
US (1) | US20040138241A1 (pt) |
EP (1) | EP1393731A1 (pt) |
JP (1) | JPWO2002083142A1 (pt) |
KR (1) | KR20030087074A (pt) |
CN (1) | CN1501802A (pt) |
BR (1) | BR0208814A (pt) |
CA (1) | CA2443910A1 (pt) |
HU (1) | HUP0303944A3 (pt) |
RU (1) | RU2003133136A (pt) |
WO (1) | WO2002083142A1 (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003207089A1 (en) * | 2003-02-14 | 2004-09-06 | Takeda Pharmaceutical Company Limited | Preparation for topical administration |
EP2363397A4 (en) * | 2008-11-07 | 2012-07-11 | Dainippon Sumitomo Pharma Co | NEW THERAPEUTIC AGENT USEFUL FOR SYMPTOM OF LOWER URINARY TRACT |
GB201616838D0 (en) * | 2016-10-04 | 2016-11-16 | Nat Univ Ireland | Hyaluronan compositions, and uses thereof in treatment of interstitial cystitis |
JP2022522068A (ja) * | 2019-02-25 | 2022-04-13 | カーディフ・オンコロジー・インコーポレイテッド | 平滑筋の非アドレナリン作動性収縮及び前立腺細胞増殖を阻害するためのオンバンサーティブ |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW414792B (en) * | 1995-12-20 | 2000-12-11 | Yamanouchi Pharma Co Ltd | An arylethensulfonamide derivative having endothelin receptor antagonistic effect and its pharmaceutical composition |
CN1295477A (zh) * | 1998-03-31 | 2001-05-16 | 田边制药株式会社 | 排尿困难的预防或治疗剂 |
-
2002
- 2002-04-11 WO PCT/JP2002/003624 patent/WO2002083142A1/ja not_active Application Discontinuation
- 2002-04-11 RU RU2003133136/15A patent/RU2003133136A/ru not_active Application Discontinuation
- 2002-04-11 JP JP2002580946A patent/JPWO2002083142A1/ja not_active Withdrawn
- 2002-04-11 KR KR10-2003-7013289A patent/KR20030087074A/ko not_active Application Discontinuation
- 2002-04-11 HU HU0303944A patent/HUP0303944A3/hu unknown
- 2002-04-11 BR BR0208814-2A patent/BR0208814A/pt not_active IP Right Cessation
- 2002-04-11 US US10/474,671 patent/US20040138241A1/en not_active Abandoned
- 2002-04-11 EP EP02724610A patent/EP1393731A1/en not_active Withdrawn
- 2002-04-11 CA CA002443910A patent/CA2443910A1/en not_active Abandoned
- 2002-04-11 CN CNA028081498A patent/CN1501802A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
HUP0303944A3 (en) | 2005-06-28 |
WO2002083142A1 (fr) | 2002-10-24 |
CN1501802A (zh) | 2004-06-02 |
RU2003133136A (ru) | 2005-03-10 |
KR20030087074A (ko) | 2003-11-12 |
EP1393731A1 (en) | 2004-03-03 |
JPWO2002083142A1 (ja) | 2004-08-05 |
CA2443910A1 (en) | 2002-10-24 |
US20040138241A1 (en) | 2004-07-15 |
HUP0303944A2 (hu) | 2004-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR10114A (es) | Composiciones farmacéuticas que comprenden inhibidoras de la hmg coa reductasa (divisional del exp. 6687) | |
ATE468332T1 (de) | Phenyl-(4-(3-phenyl-1h-pyrazol-4-yl)-pyrimidin- - yi)aminderivate | |
BR0316152A (pt) | Compostos de pirimidina | |
ECSP034773A (es) | Pirazolopirimmidinas como agentes terapeuticos | |
CY1114803T1 (el) | Παραγωγα πυριμιδινο σουλφοναμιδιου ως ρυθμιστες υποδοχεων χημειοκινης | |
RS51923B (en) | SO 4 [[4 - [[4- (2-CYANOETHENYL) -2,6-DIMETHYLPHENYL] AMINO] -2-PYRIMIDINYL] AMINO] BENZONITRILA | |
AU2002344951A1 (en) | Substituted piperazine and diazepanes as histamine h3 receptor agonists | |
WO2007042786A3 (en) | 4 -heteroaryl pyrimidine derivatives and use thereof as protein kinase inhibitors | |
ES2187300A1 (es) | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos. | |
CO5590918A2 (es) | Formulaciones | |
ES2421948T3 (es) | Compuestos y composiciones para suministrar agentes activos | |
SG147450A1 (en) | Sustained release pharmaceutical compositions comprising aplindore and derivatives thereof | |
BR0314182A (pt) | Formulações compreendendo um composto de indolinona | |
BRPI0607811B8 (pt) | derivados de óxido de pirimidina de 2-(4-cianofenilamino) inibidores de hiv, composição farmacêutica compreendendo os mesmos, processo para preparar a referida composição e uso | |
ATE523498T1 (de) | Hiv-inhibierende 2-(4- cyanophenylamino)pyrimidinderivate | |
BR0113590A (pt) | 7-oxo-piridopirimidinas | |
BR0017120A (pt) | Composição farmacêutica | |
BR9916887A (pt) | Uso de derivados de pirimidina | |
BR0208814A (pt) | Uso de derivados de ariletenossulfonamida | |
PA8545601A1 (es) | Derivados de 4-aminopirimidina | |
WO2010030201A3 (en) | Stable oral pharmaceutical composition containing a pharmaceutically acceptable salt of [(e)-7-[4-(4-fluorophenyl)-6-isopropyl-2- [methyl(methylsulfonyl)amino]pyrimidine-5-yl] (3r, 5s) - 3,5 dihydroxyhept-6- enoic acid | |
BRPI0412453A (pt) | uso do ácido ascórbico ou um sal fisiologicamente aceitável do mesmo | |
PA8556101A1 (es) | 2-amino-6-(fenilo sustituido en las posiciones 2,4,5)-piridinas | |
AR032695A1 (es) | Composicion farmaceutica | |
MX2021014830A (es) | Conjugados de compuestos que comprenden nitrogeno heteroaromatico donador de pares de electrones pi. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A,6A E 7A ANUIDADES |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2029 DE 24/11/2009. |